Home/i-Cordis/Douglas Mann, MD

DM

Douglas Mann, MD

Founder

Therapeutic Areas

i-Cordis Pipeline

Drug	Indication	Phase
PEGylated Pirfenidone	Heart Failure with Preserved Ejection Fraction (HFpEF)	Pre-clinical

Leadership Team at i-Cordis

Luigi Adamo, MD, PhD

Jennifer Riggs, PhD

Head of Medicinal Chemistry

Bradley Keller, PhD

VP Preclinical Development

Jennifer Baltz, PhD

Chief Operating Officer

View full i-Cordis profile